Catalyst Pharmaceuticals Reports Fourth Quarter and Full
Achieved Record 2022 Total Net Revenues of $214 Million, a 52% YoY Increase Achieved FIRDAPSE® Q4 2022 Net Product Revenues of $61 Million, a 59% YoY...
Source: globenewswire.com
Page 3 - Dydo Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dydo Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dydo Pharma Today - Breaking & Trending Today
Catalyst Pharmaceuticals Inc. (CPRX) is primed for evolution with the beta value of 1.30
For the readers interested in the stock health of Catalyst Pharmaceuticals Inc. (CPRX). It is currently valued at $7.18. When the transactions were called off in the previous session, Stock hit the highs of $7.21, after setting-off with the price of $6.99. Company’s stock value dipped to $6.925 du
Source: investchronicle.com